Daimon et al. conducted 5-year follow-up examinations and showed that decreased serum adiponectin levels were an independent risk factor for the progression to T2DM in a Japanese population (Daimon et al. 2012), suggesting that subjects in Q1 were more likely to develop T2DM than those in Q4. Here, ADIPOQ is linked to type 2 diabetes mellitus.